Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study Of Adjuvant Cisplatin-Gemcitabine Vs. Observation After Radical Cystectomy In High-Risk Bladder Cancer

NCT00054626 is registered in ClinicalTrials.gov with Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy as lead sponsor.

NCT NCT00054626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00054626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study Of Adjuvant Cisplatin-Gemcitabine Vs. Observation After Radical Cystectomy In High-Risk Bladder Cancer
Lead sponsor
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2001
Completion date
Not reported
Enrollment
700 (estimated)
Sites
151

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer